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to a level below these limits of overcorrec-
tion. Subsequently, a state of controlled 
antidiuresis is maintained by the adminis-
tration of desmopressin every 6 – 8  h, a slow 
increase of the serum sodium concentra-
tion as desired with water restriction plus 
hypertonic saline or salt tablets, or the peri-
odic delaying of a dose of desmopressin to 
permit a brief water diuresis (Figure 1). 
 Both untreated and overtreated 
hyponatremia can result in disastrous neu-
rological complications. We need not choose 
between these evils. Nephrologists should 
be equally aggressive in correcting 
hyponatremia and in un-correcting it when 
their patients get too much of a good thing. 
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 In this issue of  Kidney International , Yeates 
and colleagues 1 present a well-done inter-
national comparison of the disparities fac-
ing indigenous populations in access to 
kidney transplantation. Using data from 
four national registries, they demonstrate 
that, in comparison with white populations 
of the same age, indigenous people ’ s access 
to transplantation ranges from very poor 
(US hazard ratio of 0.44) to extremely poor 
(Australia and New Zealand hazard ratio of 
0.23). Despite the diff erences in the health-
care systems, the disparities persisted. 
 Documenting disparities in medical 
care for minority populations is hardly 
news. Hundreds of publications appear in 
the literature each year showing varying 
levels of disparity across the entire range 
of medicine and health outcomes. 
 Transplantation presents an intriguing 
(and exasperating) study in the seem-
ingly intractable problem of ethnic and 
racial barriers to access. First, the rele-
vant target population (people with end-
stage renal disease) is relatively easy to 
defi ne. Second, the preferred outcome 
(transplantation) is easy to measure, and 
the desirability of the outcome is almost 
unequivocal. Transplantation is simply a 
superior alternative to dialysis. Finally, 
the underlying racial discrepancies have 
been well documented for more than 20 
years. 2,3 Reducing racial disparities has 
been a long-time goal of the transplanta-
tion community, with many eff orts to 
increase minority registration on wait 
lists among organ donors. 4 Despite this, 
the relative access of minorities to trans-
plantation remains essentially unchanged 
over the past 20 years. 5 Why is this? 
 The days of easy solutions to racial 
disparities are well behind us. In the 
mid-1960s in the United States there 
were still policies in many states that 
mandated racial segregation of patients 
in hospitals. However, because of the 
creation and enactment of Medicare in 
1966, combined with the rigorous 
enforcement of Title VI of the Civil 
Rights Act, the practice of racial segrega-
tion in hospitals in the United States was 
eliminated in a mere four months. 6 
Thankfully, such blatant and legally 
sanctioned discrimination no longer 
exists. Removing cultural and socioeco-
nomic barriers is altogether diff erent. 
 Obtaining a solid-organ transplant 
involves a number of steps, any one of 
which can present barriers to the event. 
Th ese include referral, assessment, regis-
tration, waiting time, matching criteria, 
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off ers, acceptance, and fi nally the trans-
plantation itself. Th e barriers range from 
the obvious candidates, such as income, 
health insurance coverage, and geo-
graphical distance to a transplant center, 
to the more subtle problems of cultural 
backgrounds, lack of information, and 
 ‘ latent racism. ’ In the United States, the 
lack of health insurance coverage is oft en 
cited as a major barrier. However, as 
Yeates  et al. show, 1 the United States does 
somewhat better than the other three 
countries in relative access for the indig-
enous populations. 
 Economic barriers can reach far 
beyond the costs of medical care itself. 
Th ere can be copayments, ultimate loss 
of coverage (in the United States), trans-
portation costs, and loss of income due 
to work-loss days. All of these costs are 
more burdensome to the poor and work 
against improved access. In addition, cul-
tural, language, and informational barri-
ers are more prevalent among minority 
populations. 4 
 And there is still the problem of what 
might be called latent racism. Physicians 
are less likely to see minorities as good 
transplantation candidates as compared 
with whites, 7 and, even when referred for 
evaluation, minorities are less likely to be 
wait-listed. 8 
 All of the problems facing minorities in 
general are likely exacerbated for 
indigenous populations. Indigenous pop-
ulations tend to be at the lowest end of the 
socioeconomic ladder. In addition, they 
are oft en physically isolated, making it 
more diffi  cult to integrate them into the 
medically intensive world of transplanta-
tion. 
 Perhaps the greatest barrier to resolving 
transplantation disparities is the continu-
ing divergence between the need for trans-
plants and the supply of organs. In the 
United States, the incidence of end-stage 
renal disease in people under age 65 nearly 
doubled between 1990 (29,384) and 2006 
(57,009) (Figure 1). During that same 
period, the number of transplants in that 
age range increased by only 60 % . 5 The 
result is that the wait list for kidney trans-
plants continues to grow rapidly, as does 
the average wait time until transplantation. 
It is a  de facto zero-sum game. As long as 
the supply of transplants is  constrained, 
improved access for one group will come 
only at the expense of another. This is 
hardly the prescription for rapid reduc-
tions in racial diff erential access. Th is situ-
ation is in sharp contrast to that of dialysis, 
for which facilities and machines can con-
tinue to grow to meet the demand for care. 
Th ere is no evidence at all that access to 
dialysis is particularly constrained for 
minorities in most countries. 
 It is hard to imagine that there are inno-
vative or breakthrough ideas for improving 
access for minorities that have not already 
been discussed and vetted extensively in 
the transplantation community. Th e Organ 
Donation Breakthrough Collaborative, 
sponsored by the US Health Resources and 
Services Administration, has resulted in 
some increases in deceased-donor counts, 
particularly for extended-criteria donation 
organs. It has yet to be a factor in reducing 
transplant-access disparities. 
 Until such time as there is a technologi-
cal breakthrough in organ supply, perhaps 
through xenotransplantation or stem-cell 
development, kidney and other solid-organ 
transplants will continue to be in short sup-
ply. Improvements in access for minorities 
(relative to whites) will be very slow in 
coming, if they come at all. Perhaps the best 
that can be attained is heightened aware-
ness of these issues among providers and 
patients, as well as improved educational 
eff orts among transplant interest groups. 
 DISCLOSURE 
 The author declared no competing interests. 
 ACKNOWLEDGMENTS 
 The opinions given in this essay are those of 
the author and do not represent the position 
of the National Institutes of Health, or any 
other agency or organization. 
 REFERENCES 
 1 .  Yeates  KE ,  Cass  A ,  Sequist  TD  et al.  Indigenous 
people in Australia, Canada, New Zealand and the 
United States are less likely to receive 
renal transplantation .  Kidney Int  2009 ;  76 :  
 659 – 664 . 
 2 .  Eggers  P .  Effect of transplantation on the Medicare 
End-Stage Renal Disease Program .  N Engl J Med 
 1998 ;  318 :  223 – 229 . 
 3 .  Held  P ,  Pauly  M ,  Bovjberg  R  et al.  Access 
to kidney transplantation: has the United 
States eliminated income and racial 
differences?  Arch Intern Med  1988 ;  148 :  
 2594 – 2600 . 
 4 .  Higgins  RSD ,  Fishman  JA .  Disparities in solid 
organ transplantation for ethnic minorities: 
facts and solutions .  Am J Transplant  2006 ;  6 : 
 2556 – 2562 . 
 5 .  United States Renal Data System .  2008 
Annual Data Report .  National Institutes of Health, 
National Institute of Diabetes and Digestive 
and Kidney Diseases, Bethesda, Maryland, USA , 
 2008 . 
 6 .  Eichner  J ,  Vladeck  BC .  Medicare as a catalyst for 
reducing health disparities .  Health Aff (Millwood) 
 2005 ;  24 :  365 – 375 . 
 7 .  Ayanian  JZ ,  Cleary  PD ,  Keogh  JH  et al.  Physicians ’ 
beliefs about racial differences in referral for 
renal transplantation .  Am J Kidney Dis  2004 ;  43 : 
 386 – 387 . 
 8 .  Sequist  TD ,  Narva  AS ,  Stiles  SK  et al.  Access 
to renal transplantation among American 
Indians and Hispanics .  Am J Kidney Dis  2004 ;  44 : 
 344 – 352 . 
Age
Race/ethnicity
Sex
Primary diagnosis
0–19
White
Male
Female
All
Diabetes
Hypertension
Cystic kidney
Pe
rc
en
t o
f p
at
ie
nt
s
Glomerulonephritis
African american
Native american
Asian
Hispanic
20–39
40–59
60–69
80
60
40
20
0
60
50
40
0
30
10
20
91 030199979593 91 030199979593
 Figure 1  |  Incident end-stage renal disease patients receiving a transplant within 3 years, 
by age, sex, race / ethnicity, and primary diagnosis. Incident end-stage renal disease patients 
younger than 70 years. Patients with a prior transplant are excluded. Percentages were estimated 
by the Kaplan – Meier methodology. For Hispanic patients we present data beginning in 1996, the 
first full year after the April 1995 introduction of the revised Medical Evidence form, which contains 
more specific questions on race and ethnicity. 
